Stay informed with regulatory changes, MHRA updates, and industry developments.
The MHRA and HRA are implementing new clinical trials regulations under SI 2025/538, introducing streamlined approvals.
Read update →Down from 22.9% in 2025, following the UK-US trade deal.
Read more →81% of NHS primary care medicines are unbranded generics.
Read more →MHRA data 2016-2023 confirms data integrity as top compliance concern.
Read more →Threshold rises to 25k-35k per QALY from April 2026.
Read more →UK biopharma turnover: 98.9bn. Top deficiencies: Quality Systems, Annex 1, Annex 11.
Read more →Medicines QP-certified after 31 Dec 2024 must carry "UK Only" label.
Read more →Receive pharmaceutical news updates.
Contact us for expert guidance on the latest regulations.
Get in Touch →